Case File
efta-02559972DOJ Data Set 11OtherEFTA02559972
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02559972
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
David Stem
Sent:
Tuesday, September 25, 2012 9:34 AM
To:
Jeffrey Epstein
Subject:
StanChart Bank
StanChart stake?
Had dinner with Chairman of StanChart with PA and can see him anytime.
It says JPM is interested.
Good bank for China/Asia and Africa?
September 24, 2012
Temasek reconsiders StanChart stake
Singapore investment fund Temasek has sounded out potential buyers for =ts £6bn stake in Standard Chartered,
potentially reigniting talk of a =akeover of the emerging markets bank.
The fund, which is owned by the Singapore government, had been judging =uyer interest for its 18 per cent shareholding
in recent months, said =eople close to the situation.
Bankers said earlier momentum for a sale fell last month as StanChart's =hares dropped 20 per cent on the day it was
accused by a US regulator =f breaching US sanctions on Iran. After settling the dispute with a =340m payment, the
bank's share price has rebounded.
Temasek became StanChart's biggest single shareholder six years ago, =uying out the 11.5 per cent stake of the Khoo
family for a small =ndisclosed discount to its then market value of E2.3bn. The family =ad been the bank's protector
since the 1980s, when it had become the =ubject of an unwelcome bid from Lloyds Bank.
StanChart, which has its headquarters in the UK but a business focus on =he emerging markets of Asia and the Middle
East, is one of the few =lobally active banks to be largely unscathed by the financial crisis. =t has attracted interest from
the likes of JPMorgan and Santander, =ccording to bankers. Although private discussions have taken place, =othing has
come of them, largely because StanChart's robust valuation =96 its market capitalisation is £35bn — would make it hard
to =wallow.
StanChart trades at a 1.4 times multiple of book value at a time when =any rivals, particularly in Europe, trade on less
than half that. =nalysts said Temasek might be keen to take advantage of the relative =trength and reduce its exposure
to financial services, given the =conomic uncertainty.
Bankers believe any ambition Temasek might have had to engineer a merger =etween StanChart and another of its
investments, Singaporean bank DEIS, =as faded, given the complexities and regulatory hostility to big =anking mergers.
Temasek has hired two western bankers — Greg Curl from Bank of America =errill Lynch and John Cryan, former finance
director of Swiss bank UBS =96 to help oversee its stakes in businesses in the US and Europe. =eople close to the
situation stressed that there were no live =iscussions with any potential buyer. Both Temasek and StanChart =eclined to
comment.
Temasek signalled a move away from its StanChart stake a year ago when =t issued an innovative convertible bond that
would convert into =tanChart shares under some circumstances.
The three-year bond, which raised more than $600m, would potentially =have nearly 1 percentage point off the fund's
total stake if the =ank's shares rise beyond the prerequisite 27 per cent premium to the =hen share price of £14.29. The
shares closed on Monday at £14.81.
After the row over sanctions, people close to the bank signalled an =ccelerated shake-up of its board, which was
criticised by shareholders =arlier in the year. Temasek withheld support for the re-election of =xecutive directors except
chief executive Peter Sands and two =on-executives.
EFTA_R1_01720715
EFTA02559972
<?xml version=.0" encoding=TF-8"?>
<!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/Propertylist-1.0.dtd">
<plist version=.0">
<dict>
<key>conversation-idgkey>
<integer>231351</integer>
<key>date-last-viewed</key>
<integer>0</integer>
<key>date-received</key>
<integer>1348565614</integer>
<key>flags</key>
<integer>8623750145</integer>
<key>gmail-label-ids</key>
<array>
<integer>6</integer>
<integer>2</integer>
</array>
<key>remote-id</key>
<string>247892</string>
</dict>
</plist>
2
EFTA_R1_01720716
EFTA02559973
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2559972Phone
2559973Phone
8565614Phone
8623750145URL
http://www.apple.com/DTDs/Propertylist-1.0.dtdRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.